Alida Griffith

4.7k total citations · 1 hit paper
25 papers, 1.8k citations indexed

About

Alida Griffith is a scholar working on Neurology, Molecular Biology and Neurology. According to data from OpenAlex, Alida Griffith has authored 25 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Neurology, 9 papers in Molecular Biology and 8 papers in Neurology. Recurrent topics in Alida Griffith's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological diseases and metabolism (7 papers) and RNA regulation and disease (5 papers). Alida Griffith is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological diseases and metabolism (7 papers) and RNA regulation and disease (5 papers). Alida Griffith collaborates with scholars based in United States, United Kingdom and Greece. Alida Griffith's co-authors include Cyrus P. Zabetian, Ali Samii, John W. Roberts, Haydeh Payami, Denise M. Kay, Stewart A. Factor, John G. Nutt, Dora Yearout, Berta C. Leis and Jennifer S. Montimurro and has published in prestigious journals such as Nature Genetics, Neurology and Annals of Neurology.

In The Last Decade

Alida Griffith

23 papers receiving 1.7k citations

Hit Papers

Common genetic variation in the HLA region is associated ... 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alida Griffith United States 16 1.3k 632 541 451 434 25 1.8k
Dora Yearout United States 18 1.3k 1.0× 624 1.0× 542 1.0× 487 1.1× 443 1.0× 24 1.8k
Julie P. Taylor United States 15 1.2k 1.0× 503 0.8× 425 0.8× 604 1.3× 377 0.9× 17 1.6k
Jennifer S. Montimurro United States 14 983 0.8× 442 0.7× 487 0.9× 396 0.9× 231 0.5× 16 1.4k
Mark S. Moehle United States 17 1.1k 0.8× 492 0.8× 568 1.0× 610 1.4× 399 0.9× 27 1.7k
Ayşe Ulusoy Germany 22 1.4k 1.1× 351 0.6× 808 1.5× 625 1.4× 415 1.0× 36 2.0k
Kelly M. Hinkle United States 15 759 0.6× 269 0.4× 329 0.6× 323 0.7× 372 0.9× 18 1.1k
Kateřina Venderová United States 13 574 0.4× 172 0.3× 436 0.8× 438 1.0× 227 0.5× 17 1.2k
Marie L. Schmidt United States 17 1.1k 0.9× 451 0.7× 496 0.9× 615 1.4× 1.3k 3.0× 22 2.0k
Isabella Russo Italy 22 692 0.5× 509 0.8× 438 0.8× 583 1.3× 514 1.2× 39 1.5k
Anthony DelleDonne United States 17 1.0k 0.8× 581 0.9× 446 0.8× 406 0.9× 790 1.8× 21 1.9k

Countries citing papers authored by Alida Griffith

Since Specialization
Citations

This map shows the geographic impact of Alida Griffith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alida Griffith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alida Griffith more than expected).

Fields of papers citing papers by Alida Griffith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alida Griffith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alida Griffith. The network helps show where Alida Griffith may publish in the future.

Co-authorship network of co-authors of Alida Griffith

This figure shows the co-authorship network connecting the top 25 collaborators of Alida Griffith. A scholar is included among the top collaborators of Alida Griffith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alida Griffith. Alida Griffith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Seeberger, Lauren, et al.. (2011). Rasagiline. The Neurologist. 17(6). 318–324. 7 indexed citations
3.
Hamza, Taye H., Cyrus P. Zabetian, Albert Tenesa, et al.. (2010). Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nature Genetics. 42(9). 781–785. 584 indexed citations breakdown →
4.
Furlong, Clement E., Stephanie M. Suzuki, Richard Stevens, et al.. (2010). Human PON1, a biomarker of risk of disease and exposure. Chemico-Biological Interactions. 187(1-3). 355–361. 95 indexed citations
5.
Hall, Deborah A., et al.. (2009). MOVEMENT DISORDERS ASSOCIATED WITH ARIPIPRAZOLE USE: A CASE SERIES. International Journal of Neuroscience. 119(12). 2274–2279. 15 indexed citations
6.
Hutter, Carolyn M., Ali Samii, Stewart A. Factor, et al.. (2008). Lack of evidence for an association between UCHL1 S18Y and Parkinson’s disease. European Journal of Neurology. 15(2). 134–139. 25 indexed citations
7.
Ross, Owen A., Cleanthe Spanaki, Alida Griffith, et al.. (2008). Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism. Parkinsonism & Related Disorders. 15(6). 466–467. 30 indexed citations
8.
Kay, Denise M., Stewart A. Factor, Ali Samii, et al.. (2008). Genetic association between α‐synuclein and idiopathic parkinson's disease. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(7). 1222–1230. 55 indexed citations
9.
Mata, Ignácio F., Ali Samii, John W. Roberts, et al.. (2008). Glucocerebrosidase Gene Mutations. Archives of Neurology. 65(3). 379–82. 155 indexed citations
10.
Agarwal, Pinky & Alida Griffith. (2008). Restless legs syndrome: a unique case and essentials of diagnosis and treatment.. PubMed. 10(12). 296–296. 2 indexed citations
11.
McCulloch, Colin, Denise M. Kay, Stewart A. Factor, et al.. (2008). Exploring gene-environment interactions in Parkinson’s disease. Human Genetics. 123(3). 257–265. 72 indexed citations
12.
Powers, Karen M., Denise M. Kay, Stewart A. Factor, et al.. (2007). Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk. Movement Disorders. 23(1). 88–95. 105 indexed citations
13.
Zabetian, Cyrus P., Carolyn M. Hutter, Stewart A. Factor, et al.. (2007). Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease. Annals of Neurology. 62(2). 137–144. 113 indexed citations
14.
Samii, Ali, Carolyn M. Hutter, Alida Griffith, et al.. (2007). DBH −1021C→T does not modify risk or age at onset in Parkinson's disease. Annals of Neurology. 62(1). 99–101. 5 indexed citations
15.
Kay, Denise M., T. Bird, Cyrus P. Zabetian, et al.. (2006). Validity and Utility of a LRRK2 G2019S Mutation Test for the Diagnosis of Parkinson's Disease. Genetic Testing. 10(3). 221–227. 17 indexed citations
16.
Zabetian, Cyrus P., Carolyn M. Hutter, Dora Yearout, et al.. (2006). LRRK2 G2019S in Families with Parkinson Disease Who Originated from Europe and the Middle East: Evidence of Two Distinct Founding Events Beginning Two Millennia Ago. The American Journal of Human Genetics. 79(4). 752–758. 87 indexed citations
17.
Ishihara, Lianna, Liling Warren, Rachel A. Gibson, et al.. (2006). Clinical Features of Parkinson Disease Patients With Homozygous Leucine-Rich Repeat Kinase 2 G2019S Mutations. Archives of Neurology. 63(9). 1250–1250. 74 indexed citations
18.
Zabetian, Cyrus P., Hiroyuki Morino, Hiroshi Ujike, et al.. (2006). Identification and haplotype analysis of LRRK2 G2019S in Japanese patients with Parkinson disease. Neurology. 67(4). 697–699. 48 indexed citations
19.
Griffith, Alida, et al.. (2000). Exacerbation of Multiple Sclerosis Following Wasp Stings. Mayo Clinic Proceedings. 75(3). 317–318. 1 indexed citations
20.
Griffith, Alida, et al.. (2000). Exacerbation of Multiple Sclerosis Following Wasp Stings. Mayo Clinic Proceedings. 75(3). 317–318. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026